glp-1/gip/glucagon receptor agonist New strategies for the treatment of obesity and metabolic dysfunctions The Road towards Triple Agonists:
Description
Lancet Diab Endocrinol
Funding Not applicable
Furness, J
Sudden inflammation of the pancreas may occur with these medications, though it is rare
P., Engstrom, T
If cost, access, or dosing preferences point toward compounded semaglutide or tirzepatide, your genetic and biomarker profile remains relevant
